USP26 and neoplasm: Furthermore, using the REMBRANDT (Repository for Molecular BRAin Neoplasia DaTA) database, we found that glioblastoma patients with low levels of USP26 had a lower overall survival than patients with high levels of USP26 (Fig 4D).